Sector ratings Iqvia Holdings Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:02 2025-12-05 pm EST			5-day change	1st Jan Change
225.85 ^USD	+0.41%		-1.81%	+14.93%

Dec. 02	Amneal Pharmaceuticals, Inc. Receives U.S. Fda Approval for Albuterol Sulfate Inhalation Aerosol	CI
Dec. 02	Iqvia announces strategic collaboration with AWS, naming AWS as preferred agentic cloud provider to power next-generation AI platform	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
IQVIA HOLDINGS INC.	38.46B		AAA
LONZA GROUP AG	47.37B		AAA
BEONE MEDICINES AG	35.73B		-
CELLTRION, INC.	27.23B		A
MEDPACE HOLDINGS, INC.	15.44B		BBB
REVOLUTION MEDICINES, INC.	15.4B	-	B	-		-
ICON PUBLIC LIMITED COMPANY	14.19B		AA
TEMPUS AI, INC.	13.64B	-	A	-		-
IONIS PHARMACEUTICALS, INC.	13.23B	-	A	-		-
ASCENDIS PHARMA A/S	12.55B	-	-	-		-
EUROFINS SCIENTIFIC SE	12.12B		AA
QIAGEN N.V.	10.19B		AAA
BIO-TECHNE CORPORATION	9.61B		A
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	9.07B		A
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
ABIVAX	8.29B	-	BBB	-		-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	8.03B	-	-	-	-	-	-	-
PHARMARON BEIJING CO., LTD.	6.92B		AA
PRAXIS PRECISION MEDICINES, INC.	6.2B	-	B	-		-
WCG CLINICAL, INC.	6.07B	-	-	-	-	-	-	-
Average	15.91B		A
Weighted average by Cap.			A